About Us

Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.

The company is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.

Adcytherix is backed by a syndicate of leading life science investors including Pontifax, Pureos Bioventures, RA Capital Management and Dawn Biopharma (a platform controlled by KKR).

Adcytherix is based in Marseille, France.

Management Team

Jack Elands

Founder, Chief Executive Officer

Dr. Jack Elands is founder and former CEO of Emergence Therapeutics, Talix Therapeutics, CEO of BliNK Biomedical and CEO and co-founder of Amakem, CEO of Vitec, co-founder of MImAbs

Carsten Dehning

Co-founder, Chief Financial Officer

Carsten Dehning is co-founder and former CFO of Emergence Therapeutics, CFO, CEO and senior advisor of various companies and investors in the healthcare sector

Xavier Preville

Co-founder, VP and head of research & preclinical development

Dr. Xavier Preville is co-founder and former CSO of Emergence Therapeutics, CSO at Talix Therapeutics, director of preclinical development at Transgene and BT Pharma (Genticel)

Thierry Menguy

VP and head of CMC operations

Dr. Thierry Menguy is the former head of CMC at LinKinVax, CTO and co-founder at ElsaLys Biotech. He has also held senior positions in CMC and R&D of large molecules at Transgene

Inka Pawlitzky

VP and head of clinical development

Dr. Inka Pawlitzky is former senior medical director and program lead oncology at Faron Pharmaceuticals, director oncology development at Allucent and consultant at SMS Oncology

Julia Gavrilyuk

VP and head of ADC technology development

Dr. Julia Gavrilyuk is co-founder and former CEO of Yarrow Therapeutics, senior principal scientist at Abbvie, head of discovery chemistry at Stemcentrx

Holger Karsunky

VP and head of ADC discovery

Dr. Holger Karsunky is co-founder and former CSO of Yarrow Therapeutics, senior director oncology discovery at Abbvie Stemcentrx and director preclinical at Cellerant Therapeutics

Supervisory Committee

Ran Nussbaum

Managing Partner at Pontifax Venture Capital

Ohad Hammer

Partner at Pontifax Venture Capital

Ximing Ding

Investment Manager at Pureos Bioventures

Iyona Rajkomar

Managing Partner at Dawn Biopharma (a platform controlled by KKR)

Matthew Hammond

Principal at RA Capital Management